on 25 Oct 2022
Last Applicant/ Owned by
2 RESEARCH WAY
PRINCETON
NJ
08540
Serial Number
88342025 filed on 15th Mar 2019
Registration Number
6885177 registered on 25th Oct 2022
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Therapeutic pharmaceutical for the treatment of damaged skin and tissue; Therapeutic pharmaceutical for the treatment of infectious diseases, pain, inflammation, sepsis, obesity and cognitive disorders; Therapeutic pharmaceutical for the treatment of viral metabolic endocrine musculoskeletal cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory Read More
Therapeutic pharmaceutical for the treatment of damaged skin and tissue; Therapeutic pharmaceutical for the treatment of infectious diseases, pain, inflammation, sepsis, obesity and cognitive disorders; Therapeutic pharmaceutical for the treatment of viral metabolic endocrine musculoskeletal cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, psychiatric, and immune system related disease and disorders; Therapeutic pharmaceutical for the treatment of pulmonary hypertension via inhalation; Therapeutic pharmaceutical for the treatment of ocular disorders or diseases, bacteria based diseases, diabetes related complications, anti-infective preparations, antiviral preparations, antibiotics, and vaccines; Therapeutic pharmaceutical for the treatment of tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Therapeutic pharmaceutical for the treatment of wounds
28th Feb 2022
28th Feb 2022
No 88342025
No Service/Collective Mark
No 1750.T0031
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
13th Sep 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
25th Oct 2022 | REGISTERED-PRINCIPAL REGISTER |
25th Oct 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
20th Sep 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
17th Sep 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
25th Aug 2022 | STATEMENT OF USE PROCESSING COMPLETE |
23rd Aug 2022 | TEAS STATEMENT OF USE RECEIVED |
23rd Aug 2022 | USE AMENDMENT FILED |
02th Mar 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
01st Mar 2022 | SOU EXTENSION 5 GRANTED |